Skip to main content

Table 3 Association of Race-Gender Groups with Time until LDL Cholesterol Control in Cox Proportional Hazards Models Adjusted for Sequentially Added Sets of Variables

From: A Retrospective Cohort Study of the Potency of lipid-lowering therapy and Race-gender Differences in LDL cholesterol control

 

Variables Added to Model

 

Unadjusted

Socio-

demographic

Clinical

Comorbidities

Health Care

Primary Care Provider

LDL Management

 

Hazard Ratio [95% CI]

Race-gender Group

      

   Black Women

0.61

[0.53-0.69]‡

0.65

[0.56-0.76]‡

0.63

[0.54-0.74]‡

0.64

[0.54-0.75]‡

0.63

[0.53-0.74]‡

0.66

[0.56-0.78]‡

   Black Men

0.75

[0.64-0.86]‡

0.78

[0.66-0.93]†

0.77

[0.65-0.91]†

0.79

[0.66-0.94]†

0.73

[0.63-0.86]†

0.82

[0.69-0.98]*

   White Women

0.72

[0.62-0.83]‡

0.75

[0.64-0.87]‡

0.74

[0.64-0.86]‡

0.75

[0.64-0.87]‡

0.78

[0.65-0.93]‡

0.75

[0.64-0.88]†

   White Men

1.0

1.0

1.0

1.0

1.0

1.0

  1. *P < 0.05
  2. † P ≤ 0.01
  3. ‡ P ≤ 0.001
  4. Demographics [i.e., age, neighborhood income]; clinical comorbidities [i.e., vascular disease, diabetes, renal insufficiency, unrelated comorbidities, smoking]; health care [i.e., insurance, number of annual visits; visit adherence; antihypertensive medications]; primary care provider [i.e. type, race, gender, workload]; LDL management [i.e., baseline LDL, LDL checks within 6 months, and lipid-lowering drug potency].
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us